guest ::
| Home > Publications database > DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. > print |
| Home > Publications database > DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. > print |
| 001 | 301745 | ||
| 005 | 20250819093625.0 | ||
| 024 | 7 | _ | |a 10.1093/nar/gkaf435 |2 doi |
| 024 | 7 | _ | |a pmid:40444638 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC12123414 |2 pmc |
| 024 | 7 | _ | |a 0305-1048 |2 ISSN |
| 024 | 7 | _ | |a 0261-3166 |2 ISSN |
| 024 | 7 | _ | |a 1362-4954 |2 ISSN |
| 024 | 7 | _ | |a 1362-4962 |2 ISSN |
| 024 | 7 | _ | |a 1746-8272 |2 ISSN |
| 024 | 7 | _ | |a altmetric:177660179 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-01129 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Gehrs, Stephanie |0 P:(DE-He78)6c7c0079533d7a9cda3bb9f463e22ccb |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. |
| 260 | _ | _ | |a Oxford |c 2025 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1755588960_6400 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A190#LA:A190#LA:B370# / geteilte Letztautorenschaft aus unterschiedlichen Kostenstellen |
| 520 | _ | _ | |a DNA methylation plays a fundamental role in regulating transcription during development and differentiation. However, its functional role in the regulation of endothelial cell (EC) transcription during state transition, meaning the switch from an angiogenic to a quiescent cell state, has not been systematically studied. Here, we report the longitudinal changes of the DNA methylome over the lifetime of the murine pulmonary vasculature. We identified prominent alterations in hyper- and hypomethylation during the transition from angiogenic to quiescent ECs. Once a quiescent state was established, DNA methylation marks remained stable throughout EC aging. These longitudinal differentially methylated regions correlated with endothelial gene expression and highlighted the recruitment of de novo DNA methyltransferase 3a (DNMT3A), evidenced by its motif enrichment at transcriptional start sites of genes with methylation-dependent expression patterns. Loss-of-function studies in mice revealed that the absence of DNMT3A-dependent DNA methylation led to the loss of active enhancers, resulting in mild transcriptional changes, likely due to loss of active enhancer integrity. These results underline the importance of DNA methylation as a key epigenetic mechanism of EC function during state transition. Furthermore, we show that DNMT3A-dependent DNA methylation appears to be involved in establishing the histone landscape required for accurate transcriptome regulation. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a DNA Methyltransferase 3A |0 EC 2.1.1.37 |2 NLM Chemicals |
| 650 | _ | 7 | |a DNA (Cytosine-5-)-Methyltransferases |0 EC 2.1.1.37 |2 NLM Chemicals |
| 650 | _ | 7 | |a Dnmt3a protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a DNMT3A protein, human |2 NLM Chemicals |
| 650 | _ | 2 | |a DNA Methylation |2 MeSH |
| 650 | _ | 2 | |a DNA Methyltransferase 3A |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a DNA (Cytosine-5-)-Methyltransferases: genetics |2 MeSH |
| 650 | _ | 2 | |a DNA (Cytosine-5-)-Methyltransferases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Endothelial Cells: metabolism |2 MeSH |
| 650 | _ | 2 | |a Enhancer Elements, Genetic |2 MeSH |
| 650 | _ | 2 | |a Epigenesis, Genetic |2 MeSH |
| 650 | _ | 2 | |a Neovascularization, Physiologic: genetics |2 MeSH |
| 650 | _ | 2 | |a Gene Expression Regulation |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 700 | 1 | _ | |a Gu, Zuguang |b 1 |
| 700 | 1 | _ | |a Hey, Joschka |0 P:(DE-He78)198a73f54b40192a2fdc2bf53ba7ca27 |b 2 |
| 700 | 1 | _ | |a Weichenhan, Dieter |0 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f |b 3 |u dkfz |
| 700 | 1 | _ | |a Buckwalter, Niklas |0 P:(DE-He78)bb8874c831d15fe8fcb9946f98723770 |b 4 |u dkfz |
| 700 | 1 | _ | |a Jakab, Moritz Viktor |0 P:(DE-He78)e17ab05b2c7ece91a9ce3e8355fd3825 |b 5 |
| 700 | 1 | _ | |a Hotz-Wagenblatt, Agnes |0 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092 |b 6 |
| 700 | 1 | _ | |a Breuer, Kersten |0 P:(DE-He78)75efcd61c13c2fbe457cdf3454ef486c |b 7 |
| 700 | 1 | _ | |a Prada, Maria Llamazares |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Hübschmann, Daniel |0 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d |b 9 |u dkfz |
| 700 | 1 | _ | |a Schlereth, Katharina |0 P:(DE-He78)e674edaa6403c4ef34b2fae4649e654f |b 10 |
| 700 | 1 | _ | |a Plass, Christoph |0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |b 11 |e Last author |u dkfz |
| 700 | 1 | _ | |a Augustin, Hellmut |0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |b 12 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1093/nar/gkaf435 |g Vol. 53, no. 10, p. gkaf435 |0 PERI:(DE-600)1472175-2 |n 10 |p gkaf435 |t Nucleic acids research |v 53 |y 2025 |x 0305-1048 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:301745 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)6c7c0079533d7a9cda3bb9f463e22ccb |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)198a73f54b40192a2fdc2bf53ba7ca27 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)ff4024f7bc236e7897d9c18ee19c451f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)bb8874c831d15fe8fcb9946f98723770 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)e17ab05b2c7ece91a9ce3e8355fd3825 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)75efcd61c13c2fbe457cdf3454ef486c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)e674edaa6403c4ef34b2fae4649e654f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-10 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-04-03T10:37:02Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-04-03T10:37:02Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2024-04-03T10:37:02Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-10 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-10 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NUCLEIC ACIDS RES : 2022 |d 2024-12-10 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NUCLEIC ACIDS RES : 2022 |d 2024-12-10 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-10 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-10 |
| 920 | 2 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l A190 Vaskuläre Onkologie und Metastasierung |x 0 |
| 920 | 2 | _ | |0 I:(DE-He78)B370-20160331 |k B370 |l Epigenomik |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l A190 Vaskuläre Onkologie und Metastasierung |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B370-20160331 |k B370 |l Epigenomik |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)W015-20160331 |k W015 |l Innovations- und Service-Unit für Bioinformatik und Präzisionsmedizin |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)W610-20160331 |k W610 |l Core Facility Omics IT |x 4 |
| 920 | 0 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l A190 Vaskuläre Onkologie und Metastasierung |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A190-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W015-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W610-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|